Table 1: Baseline characteristics of patients under HIV care at Scottish Livingstone Hospital IDCC enrolled in the study.
Variable |
Salivary gland Hypofunction |
Normal salivary Gland function |
P-Value |
N |
Sex, n (%) |
||||
Male |
8 (47%) |
134 (35%) |
0.31 |
142 (35%) |
Female |
9 (53%) |
249 (65%) |
258 (65%) |
|
Total |
17 (4.2%) |
383 (95.8) |
400 |
|
Mean age, years (SD) |
35.52 (12.14) |
42.22 (13.50) |
0.02 |
399 |
HAART regimen, n (%) |
||||
DTG based |
15 (88) |
364 (95) |
0.22
|
379 (94.75) |
Non DTG based |
2 (12) |
19 (5) |
21 (5.25) |
|
Total |
17 (4.25) |
383 (95.75) |
400 |
|
Median years on HAART, No (IQR) |
8 (5-9) |
9 (6-14) |
0.43 |
400 |
Median CD4-CD8 ratio, No (IQR) |
0.87 (0.55-1.17) |
0.79 (0.57-1.11) |
0.95 |
395 |
Viral load category, n (%) |
||||
>= 400 |
0 |
4 (1) |
0.67 |
4 (1%) |
< 400 |
17 (100%) |
377 (99) |
394 (99%) |
|
Median CD4 count , No (IQR) |
506 (437-587) |
571 (401-787) |
0.87 |
400 |
History of TB Treatment, n (%) |
||||
Yes |
8 (47) |
51 (13.3) |
> 0.00 |
59 |
No |
9 (53) |
332 (86.7) |
341 |
|
Median xerostomia total score, No (IQR) |
5 (5-5) |
5 (5-5) |
0.98 |
400 |
Median CD8 count, No (IQR) |
715 (461-1129) |
724 (530-936) |
0.73 |
395 |